EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027

EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027

  • March 2019 •
  • 77 pages •
  • Report ID: 4844190 •
  • Format: PDF
KEY INSIGHTS
The Europe orthobiologics market growth is expected at the CAGR of 5.04% in the forecast period 2019-2027. Development of new-end technology coupled with a rise in orthopedic surgeries in European countries is the fundamental factor influencing the growth of the orthobiologics market in the Europe region.

MARKET INSIGHTS
The Europe orthobiologics market is segmented on the basis of product, end-user, application, and geography. The Europe market of orthobiologics by product is further segmented into the bone morphogenetic protein (BMP), demineralized bone matrix (DBM), synthetic bone graft substitutes, viscosupplementation, stem cell therapy, and other products.
The Europe orthobiologics market of geography is further segmented into the United Kingdom, Germany, France, Spain, Italy, and the Rest of Europe.The healthcare services provided by France are considered one of the best in the world.

Also, the high percentage of healthcare services provided by the government in this region is boosting the market scene in the European market.
COMPETITIVE ANALYSIS
Major players for the orthobiologics market are Exactech Inc., Zimmer Biomet Inc., AAP Implantate AG, Allosource, Stryker Corporation, Baxter International Inc., Medtronic Inc., Sanofi, Nuvasive Inc., Depuy Inc. (Acquired By Johnson And Johnson), Integra Lifesciences Holding Corporation, RTI Surgical, Conmed Corporation, Amedica Corporation and Smith & Nephew PLC.

Companies mentioned
1. ALLOSOURCE
2. AMEDICA CORPORATION
3. BAXTER INTERNATIONAL INC.
4. CONMED CORPORATION
5. DEPUY INC. (ACQUIRED BY JOHNSON AND JOHNSON)
6. EXACTECH INC.
7. INTEGRA LIFESCIENCES HOLDING CORPORATION
8. MEDTRONIC INC.
9. NUVASIVE INC.
10. RTI SURGICAL
11. SANOFI
12. SMITH & NEPHEW PLC
13. STRYKER CORPORATION
14. ZIMMER BIOMET INC.